It certainly has been a quieter-than-normal week in respect to broker moves. After a busy earnings season, many of Australia's leading brokers appear to be taking a well-earned break.
But not all of them. Research notes this morning reveal that brokers have named three shares to buy. Here they are:
Healthscope Ltd (ASX: HSO)
According to a note out of Ord Minnett, its analysts have upgraded the healthcare services provider to a buy rating with a $2.00 price target. Although its analysts believe Healthscope will have a difficult year and is likely to see a decline in earnings, they believe that a drop in its share price has created a buying opportunity. While I agree that it does look to be good value now, I'd rather wait for signs of improvement before making an investment.
Link Administration Holdings Ltd (ASX: LNK)
Analysts at UBS have upgraded Link to a buy rating and increased the price target on its shares to $8.85. According to its note, while there are concerns over the lack of growth in funds administration revenue and its recent acquisition, UBS believes that investors should overlook this due to its defensive and cash generating business. At the current share price I think Link could offer investors a solid risk/reward. This could make it a good option for investors today.
Syrah Resources Ltd (ASX: SYR)
A note out Credit Suisse reveals that the broker has retained its outperform rating and $7.45 price target on the graphite miner's shares. Its analysts appear to be pleased that Syrah reconfirmed its first-year production target and advised of no further delays to proceedings. I think Syrah is a great option in the resources sector. Although I would prefer to wait for production to commence, investors might want to consider taking a close look at the company today.
